Biotech company Avitide pulls in Series C funds
Lebanon, New Hampshire-based biotech company Avitide Inc has secured an undisclosed amount of Series C funding. NeoMed Management led the round with participation from previous backers Polaris Partners, OrbiMed Advisors, SV Life Sciences and Borealis Ventures. In addition to the funding, Claudio Nessi of NeoMed has been added to Avitide’s board of directors.
6 August 2015•4 mins read
